Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents


PHILIS-TSIMIKAS A., DEL PRATO S., Satman I. , BHARGAVA A., DHARMALINGAM M., SKJOTH T. V. , ...More

DIABETES OBESITY & METABOLISM, vol.15, no.8, pp.760-766, 2013 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 8
  • Publication Date: 2013
  • Doi Number: 10.1111/dom.12115
  • Title of Journal : DIABETES OBESITY & METABOLISM
  • Page Numbers: pp.760-766

Abstract

Aim: The efficacy and safety of insulin degludec (IDeg), a new basal insulin with an ultra-long duration of action, was compared to sitagliptin (Sita) in a 26-week, open-label trial.